Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2003

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

SGN-15

DRUG

Docetaxel

Trial Locations (9)

33901

Florida Cancer Specialists, Fort Myers

34952

Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie

60637

University of Chicago, Chicago

90095

UCLA Medical Center, Los Angeles

97213

Providence Health System, Portland

97227

Kaiser Permanente, Portland

98101

Virginia Mason Research Center, Seattle

98431

Madigan Army Medical Center, Tacoma

06830

Bendheim Cancer Center, Greenwich

All Listed Sponsors
lead

Seagen Inc.

INDUSTRY